These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16845681)

  • 1. Women's preferences in screening for Down syndrome.
    Deverill M; Robson S
    Prenat Diagn; 2006 Sep; 26(9):837-41. PubMed ID: 16845681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
    Spencer K; Aitken D
    Ultrasound Obstet Gynecol; 2004 Dec; 24(7):735-9. PubMed ID: 15505874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.
    Chan YM; Leung TN; Leung TY; Fung TY; Chan LW; Lau TK
    Prenat Diagn; 2006 Sep; 26(9):819-24. PubMed ID: 16832829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 6. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.
    Chan LW; Chau MC; Leung TY; Fung TY; Leung TN; Lau TK
    Prenat Diagn; 2005 Dec; 25(13):1248-52. PubMed ID: 16353273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Options for Down syndrome screening: what will women choose?
    Grant SS
    J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome.
    Ramos-Corpas DJ; Santiago JC
    Prenat Diagn; 2008 Sep; 28(9):833-8. PubMed ID: 18661488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
    Palomaki GE; Neveux LM; Haddow JE; Wyatt P
    Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia.
    Lewis SM; Cullinane FM; Carlin JB; Halliday JL
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):205-11. PubMed ID: 16704474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's interpretation of an abnormal result on measurement of fetal nuchal translucency and maternal serum screening for prenatal testing of Down syndrome.
    Khoshnood B; De Vigan C; Blondel B; Lhomme A; Vodovar V; Garel M; Goffinet F
    Ultrasound Obstet Gynecol; 2006 Sep; 28(3):242-8. PubMed ID: 16909402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
    Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuchal translucency screening: how do women actually utilize the results?
    Caughey AB; Musci TJ; Belluomini J; Main D; Otto C; Goldberg J
    Prenat Diagn; 2007 Feb; 27(2):119-23. PubMed ID: 17152116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of prenatal screening and psychological management of test decisions.
    Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
    Müller MA; Bleker OP; Bonsel GJ; Bilardo CM
    Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.